$JLL

Quinlan Larry sold $119K of JLL

Quinlan Larry sold 403 shares of JONES LANG LASALLE INC (JLL) at $295.14 ($0.12M total) on 2026-06-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Quinlan Larry
Published Jun 8, 2026, 2:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 8, 2026, 2:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$JLL
Neutral
high confidence
Mentioned
$JLL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JLLNeutralLow
01

Why it matters

Because it is a pre-arranged 10b5-1 plan sale by a director, it is generally treated as informationally weaker than unscheduled sales; it is unlikely to change the fundamental outlook by itself.

02

Market read

Provides a fresh datapoint on insider selling activity, but without new company-specific fundamentals.

03

What to watch

Traders may want to compare this sale to prior insider activity (frequency/size) and whether other directors/officers filed contemporaneous transactions.

Relevance 3/10Novelty 5/10Timing: Filed 2026-06-08 for a 2026-06-05 sale

Background

The article is an SEC Form 4 insider transaction disclosure for JLL, filed June 8, covering a June 5 open-market sale.

Company-level read

Ticker impact

$JLLNeutralHigh confidence
Context

Director Quinlan Larry filed an open-market sale of 403 shares at $295.1445 under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move based solely on this Form 4.

Evidence & confidence

The disclosure is an insider transaction (not an earnings/guidance/regulatory event) and explicitly states a pre-arranged 10b5-1 plan, which reduces interpretive edge.

Market effects

No clear sector read-through; single-company insider sale without new operational/regulatory information.

None indicated.

None indicated.

Counterpoint

Insider sales can still reflect private risk/valuation concerns, even when executed via 10b5-1, especially if multiple insiders sell around the same time.

Key entities

  • JLL

    Jones Lang LaSalle Inc.; subject of the Form 4 insider transaction.

  • Quinlan Larry

    Director who sold 403 shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JLLLowAI 8/10

JLL advises on $856M in financing across The Millennium Residences and The Offices at Winthrop Center

JLL advised on $856M in financing for Winthrop Center, including a $281M C-PACE loan for The Millennium Residences and a $575M loan for The Offices at Winthrop Center. The project, developed by Millennium Partners, features 823,856 sq ft of office space and 317 luxury residential units. According to JLL, the financing reflects strong institutional lender interest in high-quality assets.

$JLLLow

JLL Developer’s $12M Fraud Suit Alleges Numbers Were Cooked to Fit the Loan

Jones Lang LaSalle Americas Inc. (JLL) is being sued for over $12M by a developer and property owner over allegedly inflated financial projections for a luxury apartment tower in Washington, D.C. The plaintiffs claim JLL revised net operating income projections upward to meet a lender's debt-yield requirement, leading to substantial financial losses. The property was sold for $30.5M, far below JLL's projected valuation.

$JLLMed

JLL stock hits all-time high at 374.16 USD

Jones Lang LaSalle (JLL) shares hit an all-time high of $374.16. The article cites market cap of $17.14B and P/E of 17.79, and says InvestingPro data flags the stock as undervalued versus fair value. It also reports Q2 2026 results: adjusted EPS $5.26 vs $4.52 expected, revenue $6.9B vs $6.74B, raised FY 2026 adjusted EPS guidance to $24.60-$25.90, and a Raymond James price target cut to $500 from $455.

$JLLMed

Jones Lang LaSalle Incorporated Q2 2026 Earnings Call Summary

Jones Lang LaSalle (JLL) reported Q2 2026 results driven by its “One JLL” strategy and resilient business lines. Management raised full-year 2026 adjusted EPS guidance to $24.60–$25.90 and targeted mid-to-high teens leasing and mid-teens capital markets revenue growth. It cited advisory revenue up 21%, office bifurcation, and risks from slower capital raising.